24-Apr-2026
Business Wire (Sat, 25-Apr 1:00 PM ET)
Pulse Biosciences' nPulse Technology to be Featured at the Heart Rhythm Society 2026 Annual Meeting
Business Wire (Mon, 20-Apr 7:00 AM ET)
Pulse Biosciences to Host Analyst Event on April 25, 2026
Business Wire (Fri, 17-Apr 7:00 AM ET)
Pulse Biosciences Strengthens Executive Leadership Team
Business Wire (Thu, 9-Apr 7:00 AM ET)
Business Wire (Tue, 7-Apr 7:00 AM ET)
Pulse Biosciences to Present at the 25th Annual Needham Virtual Healthcare Conference
Business Wire (Thu, 2-Apr 4:05 PM ET)
Business Wire (Tue, 17-Mar 7:00 AM ET)
Business Wire (Thu, 12-Mar 7:00 AM ET)
Business Wire (Mon, 9-Mar 7:00 AM ET)
Pulse Biosciences to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
Business Wire (Thu, 5-Mar 7:00 AM ET)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
Pulse Biosciences trades on the NASDAQ stock market under the symbol PLSE.
As of April 24, 2026, PLSE stock price declined to $23.02 with 209,703 million shares trading.
PLSE has a beta of 0.88, meaning it tends to be less sensitive to market movements. PLSE has a correlation of 0.03 to the broad based SPY ETF.
PLSE has a market cap of $1.56 billion. This is considered a Small Cap stock.
Last quarter Pulse Biosciences reported $264,000 in Revenue and -$.26 earnings per share. This beat revenue expectation by $14,000 and missed earnings estimates by -$.01.
In the last 3 years, PLSE traded as high as $26.30 and as low as $3.78.
The top ETF exchange traded funds that PLSE belongs to (by Net Assets): VTI, IWM, VXF, IWO, SCHA.
PLSE has underperformed the market in the last year with a return of +19.5%, while SPY returned +31.9%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in PLSE shares. However, PLSE has outperformed the market in the last 3 month and 2 week periods, returning +52.6% and +23.3%, while SPY returned +3.8% and +5.1%, respectively. This indicates PLSE has been having a stronger performance recently.
PLSE support price is $23.02 and resistance is $25.48 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PLSE shares will trade within this expected range on the day.